Exagen and the Ohio State Innovation Foundation Announce Exclusive License Agreement and Research Collaboration for a Novel, Rule-In, Blood Test to Support the Diagnosis of FibromyalgiaGlobeNewsWire • 06/17/20
Exagen Inc. Announces Clinical Trial Conducted at Major Academic Center in Distinguishing Type 1 and Type 2 LupusGlobeNewsWire • 06/03/20
Exagen Inc. (XGN) CEO Ron Rocca on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/13/20
Exagen Inc. (XGN) CEO Ron Rocca on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 03/26/20
Exagen Appoints Debra Jeske Zack, M.D., Ph.D., as Chief Medical Officer, and Anja Kammesheidt, Ph.D.GlobeNewsWire • 03/24/20
Exagen Inc. Partners with Sonora Quest Laboratories to Offer AVISE Testing for Patients Suspected of Autoimmune DiseaseGlobeNewsWire • 03/16/20
Exagen Inc. Partners with Three California Medical Groups to Offer AVISE Testing as Covered In-Network Benefit for Their PatientsGlobeNewsWire • 03/09/20